Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Strategic Expansion into AI-Powered Healthcare Solutions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AnaptysBio Inc ANAB

Healthcare Biotechnology
AnaptysBio, Inc. is a clinical-stage biotechnology company focused on delivering immunology therapeutics. The Company is developing immune cell modulators, including two checkpoint agonists for autoimmune and inflammatory disease: rosnilimab, its PD-1 agonist, in a Phase 2b trial for the treatment of rheumatoid arthritis and in a Phase 2 trial for the treatment of ulcerative colitis; and ANB032... see more

Recent & Breaking News (NDAQ:ANAB)

ANAB DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds AnaptysBio, Inc. Shareholders with Losses in Excess of $100,000 of Class Action and Lead Plaintiff Deadline: May 26, 2020

Business Wire May 21, 2020

5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses to Contact the Firm

ACCESSWIRE IA May 21, 2020

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against of AnaptysBio, Inc. (ANAB)

GlobeNewswire May 21, 2020

TUESDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile May 21, 2020

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ANAB, BBBY, IQ, MESA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

GlobeNewswire May 20, 2020

FINAL DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses to Contact the Firm

ACCESSWIRE IA May 20, 2020

ANAB DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies AnaptysBio, Inc. Shareholders with Losses in Excess of $100,000 of Class Action and Lead Plaintiff Deadline: May 26, 2020

ACCESSWIRE IA May 20, 2020

DEADLINE ALERT for XELA, ANAB, I, BBBY: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire May 20, 2020

AnaptysBio Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In AnaptysBio, Inc. To Contact The Firm

Newsfile May 20, 2020

TUESDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile May 20, 2020

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ANAB, BIDU, GRPN and LOPE

GlobeNewswire May 19, 2020

ANAB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 26, 2020 in the Class Action Filed on Behalf of AnaptysBio, Inc. Limited Shareholders

Newsfile May 19, 2020

ANAB DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds AnaptysBio, Inc. Shareholders with Losses in Excess of $100,000 of Class Action and Lead Plaintiff Deadline: May 26, 2020

GlobeNewswire May 19, 2020

7-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA May 19, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AnaptysBio, Inc. - ANAB

ACCESSWIRE IA May 19, 2020

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of AnaptysBio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 26, 2020 - ANAB

Newsfile May 19, 2020

SHAREHOLDER ALERT: CLAIMSFILER REMINDS ANAB, LOPE, MESA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

GlobeNewswire May 18, 2020

8-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA May 18, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds AnaptysBio (ANAB) Investors: 8-DAY DEADLINE ALERT in Securities Class Action, Investors with Losses Should Contact its Attorneys

GlobeNewswire May 18, 2020

ANAB INVESTOR NOTICE: ROSEN, NATIONAL TRIAL LAWYERS, Reminds AnaptysBio, Inc. Investors of Important May 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - ANAB

GlobeNewswire May 18, 2020